Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1225 to 1235 of 1235 entries
Sorted by: Best Match Show Resources per page
Serum Cystatin C, a Sensitive Marker of Renal Function and Cardiovascular Disease, Decreases After Smoking Cessation.

Circulation reports

Funamoto M, Shimizu K, Sunagawa Y, Katanasaka Y, Miyazaki Y, Komiyama M, Yamakage H, Satoh-Asahara N, Takahashi Y, Wada H, Hasegawa K, Morimoto T.
PMID: 33693109
Circ Rep. 2019 Nov 30;1(12):623-627. doi: 10.1253/circrep.CR-19-0052.

No abstract available.

Cite
Funamoto M, Shimizu K, Sunagawa Y, et al. Serum Cystatin C, a Sensitive Marker of Renal Function and Cardiovascular Disease, Decreases After Smoking Cessation. Circ Rep. 2019;1(12):623-627doi: 10.1253/circrep.CR-19-0052.
Funamoto, M., Shimizu, K., Sunagawa, Y., Katanasaka, Y., Miyazaki, Y., Komiyama, M., Yamakage, H., Satoh-Asahara, N., Takahashi, Y., Wada, H., Hasegawa, K., & Morimoto, T. (2019). Serum Cystatin C, a Sensitive Marker of Renal Function and Cardiovascular Disease, Decreases After Smoking Cessation. Circulation reports, 1(12), 623-627. https://doi.org/10.1253/circrep.CR-19-0052
Funamoto, Masafumi, et al. "Serum Cystatin C, a Sensitive Marker of Renal Function and Cardiovascular Disease, Decreases After Smoking Cessation." Circulation reports vol. 1,12 (2019): 623-627. doi: https://doi.org/10.1253/circrep.CR-19-0052
Funamoto M, Shimizu K, Sunagawa Y, Katanasaka Y, Miyazaki Y, Komiyama M, Yamakage H, Satoh-Asahara N, Takahashi Y, Wada H, Hasegawa K, Morimoto T. Serum Cystatin C, a Sensitive Marker of Renal Function and Cardiovascular Disease, Decreases After Smoking Cessation. Circ Rep. 2019 Nov 30;1(12):623-627. doi: 10.1253/circrep.CR-19-0052. PMID: 33693109; PMCID: PMC7897701.
Copy Download .nbib Format: NLM
Celiac Disease Diagnosed after Gastrectomy for Gastric Cancer.

Internal medicine (Tokyo, Japan)

Iwamoto M, Kato K, Kusumi Y, Masuda S, Nakayama T, Moriyama M.
PMID: 34334571
Intern Med. 2021 Jul 30; doi: 10.2169/internalmedicine.7901-21. Epub 2021 Jul 30.

Celiac disease is a systemic autoimmune disorder leading to manifestations of malabsorption syndrome. A 47-year-old Japanese man developed severe diarrhea after surgery for gastric cancer. The diarrhea persisted for seven months, leading to a state of malabsorption. Celiac disease...

Cite
Iwamoto M, Kato K, Kusumi Y, et al. Celiac Disease Diagnosed after Gastrectomy for Gastric Cancer. Intern Med. 2021;doi: 10.2169/internalmedicine.7901-21.
Iwamoto, M., Kato, K., Kusumi, Y., Masuda, S., Nakayama, T., & Moriyama, M. (2021). Celiac Disease Diagnosed after Gastrectomy for Gastric Cancer. Internal medicine (Tokyo, Japan), . https://doi.org/10.2169/internalmedicine.7901-21
Iwamoto, Maho, et al. "Celiac Disease Diagnosed after Gastrectomy for Gastric Cancer." Internal medicine (Tokyo, Japan) vol. (2021). doi: https://doi.org/10.2169/internalmedicine.7901-21
Iwamoto M, Kato K, Kusumi Y, Masuda S, Nakayama T, Moriyama M. Celiac Disease Diagnosed after Gastrectomy for Gastric Cancer. Intern Med. 2021 Jul 30; doi: 10.2169/internalmedicine.7901-21. Epub 2021 Jul 30. PMID: 34334571.
Copy Download .nbib Format: NLM
Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction.

Gut

Yamao K, Kitano M, Chiba Y, Ogura T, Eguchi T, Moriyama I, Yamashita Y, Kato H, Kayahara T, Hoki N, Okabe Y, Shiomi H, Nakai Y, Kushiyama Y, Fujimoto Y, Hayashi S, Bamba S, Kudo Y, Azemoto N, Ueki T, Uza N, Asada M, Matsumoto K, Nebiki H, Takihara H, Noguchi C, Kamada H, Nakase K, Goto D, Sanuki T, Koga T, Hashimoto S, Nishikiori H, Serikawa M, Hanada K, Hirao K, Ohana M, Kazuyuki I, Kato T, Yoshida M, Kawamoto H.
PMID: 33223499
Gut. 2021 Jul;70(7):1244-1252. doi: 10.1136/gutjnl-2020-320775. Epub 2020 Nov 22.

OBJECTIVE: Stenting is an established endoscopic therapy for malignant gastric outlet obstruction (mGOO). The choice of stent (covered vs uncovered) has been examined in prior randomised studies without clear results.DESIGN: In a multicentre randomised prospective study, we compared covered...

Cite
Yamao K, Kitano M, Chiba Y, et al. Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction. Gut. 2020;70(7):1244-1252doi: 10.1136/gutjnl-2020-320775.
Yamao, K., Kitano, M., Chiba, Y., Ogura, T., Eguchi, T., Moriyama, I., Yamashita, Y., Kato, H., Kayahara, T., Hoki, N., Okabe, Y., Shiomi, H., Nakai, Y., Kushiyama, Y., Fujimoto, Y., Hayashi, S., Bamba, S., Kudo, Y., Azemoto, N., Ueki, T., Uza, N., Asada, M., Matsumoto, K., Nebiki, H., Takihara, H., Noguchi, C., Kamada, H., Nakase, K., Goto, D., Sanuki, T., Koga, T., Hashimoto, S., Nishikiori, H., Serikawa, M., Hanada, K., Hirao, K., Ohana, M., Kazuyuki, I., Kato, T., Yoshida, M., & Kawamoto, H. (2021). Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction. Gut, 70(7), 1244-1252. https://doi.org/10.1136/gutjnl-2020-320775
Yamao, Kentaro, et al. "Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction." Gut vol. 70,7 (2021): 1244-1252. doi: https://doi.org/10.1136/gutjnl-2020-320775
Yamao K, Kitano M, Chiba Y, Ogura T, Eguchi T, Moriyama I, Yamashita Y, Kato H, Kayahara T, Hoki N, Okabe Y, Shiomi H, Nakai Y, Kushiyama Y, Fujimoto Y, Hayashi S, Bamba S, Kudo Y, Azemoto N, Ueki T, Uza N, Asada M, Matsumoto K, Nebiki H, Takihara H, Noguchi C, Kamada H, Nakase K, Goto D, Sanuki T, Koga T, Hashimoto S, Nishikiori H, Serikawa M, Hanada K, Hirao K, Ohana M, Kazuyuki I, Kato T, Yoshida M, Kawamoto H. Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction. Gut. 2021 Jul;70(7):1244-1252. doi: 10.1136/gutjnl-2020-320775. Epub 2020 Nov 22. PMID: 33223499; PMCID: PMC8223634.
Copy Download .nbib Format: NLM
Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction.

Gut

Yamao K, Kitano M, Chiba Y, Ogura T, Eguchi T, Moriyama I, Yamashita Y, Kato H, Kayahara T, Hoki N, Okabe Y, Shiomi H, Nakai Y, Kushiyama Y, Fujimoto Y, Hayashi S, Bamba S, Kudo Y, Azemoto N, Ueki T, Uza N, Asada M, Matsumoto K, Nebiki H, Takihara H, Noguchi C, Kamada H, Nakase K, Goto D, Sanuki T, Koga T, Hashimoto S, Nishikiori H, Serikawa M, Hanada K, Hirao K, Ohana M, Kazuyuki I, Kato T, Yoshida M, Kawamoto H.
PMID: 33223499
Gut. 2021 Jul;70(7):1244-1252. doi: 10.1136/gutjnl-2020-320775. Epub 2020 Nov 22.

OBJECTIVE: Stenting is an established endoscopic therapy for malignant gastric outlet obstruction (mGOO). The choice of stent (covered vs uncovered) has been examined in prior randomised studies without clear results.DESIGN: In a multicentre randomised prospective study, we compared covered...

Cite
Yamao K, Kitano M, Chiba Y, et al. Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction. Gut. 2020;70(7):1244-1252doi: 10.1136/gutjnl-2020-320775.
Yamao, K., Kitano, M., Chiba, Y., Ogura, T., Eguchi, T., Moriyama, I., Yamashita, Y., Kato, H., Kayahara, T., Hoki, N., Okabe, Y., Shiomi, H., Nakai, Y., Kushiyama, Y., Fujimoto, Y., Hayashi, S., Bamba, S., Kudo, Y., Azemoto, N., Ueki, T., Uza, N., Asada, M., Matsumoto, K., Nebiki, H., Takihara, H., Noguchi, C., Kamada, H., Nakase, K., Goto, D., Sanuki, T., Koga, T., Hashimoto, S., Nishikiori, H., Serikawa, M., Hanada, K., Hirao, K., Ohana, M., Kazuyuki, I., Kato, T., Yoshida, M., & Kawamoto, H. (2021). Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction. Gut, 70(7), 1244-1252. https://doi.org/10.1136/gutjnl-2020-320775
Yamao, Kentaro, et al. "Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction." Gut vol. 70,7 (2021): 1244-1252. doi: https://doi.org/10.1136/gutjnl-2020-320775
Yamao K, Kitano M, Chiba Y, Ogura T, Eguchi T, Moriyama I, Yamashita Y, Kato H, Kayahara T, Hoki N, Okabe Y, Shiomi H, Nakai Y, Kushiyama Y, Fujimoto Y, Hayashi S, Bamba S, Kudo Y, Azemoto N, Ueki T, Uza N, Asada M, Matsumoto K, Nebiki H, Takihara H, Noguchi C, Kamada H, Nakase K, Goto D, Sanuki T, Koga T, Hashimoto S, Nishikiori H, Serikawa M, Hanada K, Hirao K, Ohana M, Kazuyuki I, Kato T, Yoshida M, Kawamoto H. Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction. Gut. 2021 Jul;70(7):1244-1252. doi: 10.1136/gutjnl-2020-320775. Epub 2020 Nov 22. PMID: 33223499; PMCID: PMC8223634.
Copy Download .nbib Format: NLM
A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation.

Journal of cardiology

Nagano T, Yasuoka R, Tanaka M, Maruyama M, Nakazawa G, Kurita T.
PMID: 34756768
J Cardiol. 2022 Feb;79(2):283-290. doi: 10.1016/j.jjcc.2021.09.009. Epub 2021 Oct 30.

BACKGROUND: Direct oral anticoagulants (DOACs) have been used to prevent cardiogenic embolism in patients with atrial fibrillation (AF). No evidence has been established for the follow-up renal function evaluation intervals. We hypothesized that a proposed follow-up interval of renal...

Cite
Nagano T, Yasuoka R, Tanaka M, et al. A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation. J Cardiol. 2021;79(2):283-290doi: 10.1016/j.jjcc.2021.09.009.
Nagano, T., Yasuoka, R., Tanaka, M., Maruyama, M., Nakazawa, G., & Kurita, T. (2022). A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation. Journal of cardiology, 79(2), 283-290. https://doi.org/10.1016/j.jjcc.2021.09.009
Nagano, Tomoya, et al. "A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation." Journal of cardiology vol. 79,2 (2022): 283-290. doi: https://doi.org/10.1016/j.jjcc.2021.09.009
Nagano T, Yasuoka R, Tanaka M, Maruyama M, Nakazawa G, Kurita T. A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation. J Cardiol. 2022 Feb;79(2):283-290. doi: 10.1016/j.jjcc.2021.09.009. Epub 2021 Oct 30. PMID: 34756768.
Copy Download .nbib Format: NLM
Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1.

Journal of virology

Yato K, Onodera T, Matsuda M, Moriyama S, Fujimoto A, Watashi K, Aizaki H, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Tamura K, Takahashi Y, Wakita T, Muramatsu M, Kato T, Suzuki R.
PMID: 33298539
J Virol. 2020 Dec 09; doi: 10.1128/JVI.01680-20. Epub 2020 Dec 09.

Hepatitis B virus (HBV) infection is a major public health problem. Human hepatocytes are infected with HBV via binding between the preS1 region in the large envelope protein of HBV and sodium taurocholate cotransporting polypeptide. Although several monoclonal antibodies...

Cite
Yato K, Onodera T, Matsuda M, et al. Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1. J Virol. 2020;doi: 10.1128/JVI.01680-20.
Yato, K., Onodera, T., Matsuda, M., Moriyama, S., Fujimoto, A., Watashi, K., Aizaki, H., Tanaka, T., Moriishi, K., Nishitsuji, H., Shimotohno, K., Tamura, K., Takahashi, Y., Wakita, T., Muramatsu, M., Kato, T., & Suzuki, R. (2020). Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1. Journal of virology, . https://doi.org/10.1128/JVI.01680-20
Yato, Keigo, et al. "Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1." Journal of virology vol. (2020). doi: https://doi.org/10.1128/JVI.01680-20
Yato K, Onodera T, Matsuda M, Moriyama S, Fujimoto A, Watashi K, Aizaki H, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Tamura K, Takahashi Y, Wakita T, Muramatsu M, Kato T, Suzuki R. Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1. J Virol. 2020 Dec 09; doi: 10.1128/JVI.01680-20. Epub 2020 Dec 09. PMID: 33298539; PMCID: PMC8092832.
Copy Download .nbib Format: NLM
Correlation between the position of the glenoid fossa and condylar translational movement in skeletal Class III mandibular asymmetry patients.

European journal of orthodontics

Tun Oo L, Miyamoto JJ, Takada JI, Moriyama K.
PMID: 34546345
Eur J Orthod. 2021 Sep 21; doi: 10.1093/ejo/cjab060. Epub 2021 Sep 21.

OBJECTIVES: Understanding the mechanism of mandibular asymmetry (MA) is important to provide suggestions for occlusal treatment and to know the developmental process of masticatory dysfunction. To investigate the morphological and functional effects on MA, we evaluated the three-dimensional position...

Cite
Tun Oo L, Miyamoto JJ, Takada JI, et al. Correlation between the position of the glenoid fossa and condylar translational movement in skeletal Class III mandibular asymmetry patients. Eur J Orthod. 2021;doi: 10.1093/ejo/cjab060.
Tun Oo, L., Miyamoto, J. J., Takada, J. I., & Moriyama, K. (2021). Correlation between the position of the glenoid fossa and condylar translational movement in skeletal Class III mandibular asymmetry patients. European journal of orthodontics, . https://doi.org/10.1093/ejo/cjab060
Tun Oo, Lin, et al. "Correlation between the position of the glenoid fossa and condylar translational movement in skeletal Class III mandibular asymmetry patients." European journal of orthodontics vol. (2021). doi: https://doi.org/10.1093/ejo/cjab060
Tun Oo L, Miyamoto JJ, Takada JI, Moriyama K. Correlation between the position of the glenoid fossa and condylar translational movement in skeletal Class III mandibular asymmetry patients. Eur J Orthod. 2021 Sep 21; doi: 10.1093/ejo/cjab060. Epub 2021 Sep 21. PMID: 34546345.
Copy Download .nbib Format: NLM
D-Fructose Assimilation and Fermentation by Yeasts Belonging to Saccharomycetes: Rediscovery of Universal Phenotypes and Elucidation of Fructophilic Behaviors in .

Microorganisms

Endoh R, Horiyama M, Ohkuma M.
PMID: 33916327
Microorganisms. 2021 Apr 05;9(4). doi: 10.3390/microorganisms9040758.

The purpose of this study was to investigate the ability of ascomycetous yeasts to assimilate/ferment d-fructose. This ability of the vast majority of yeasts has long been neglected since the standardization of the methodology around 1950, wherein fructose was...

Cite
Endoh R, Horiyama M, Ohkuma M. D-Fructose Assimilation and Fermentation by Yeasts Belonging to Saccharomycetes: Rediscovery of Universal Phenotypes and Elucidation of Fructophilic Behaviors in . Microorganisms. 2021;9(4)doi: 10.3390/microorganisms9040758.
Endoh, R., Horiyama, M., & Ohkuma, M. (2021). D-Fructose Assimilation and Fermentation by Yeasts Belonging to Saccharomycetes: Rediscovery of Universal Phenotypes and Elucidation of Fructophilic Behaviors in . Microorganisms, 9(4), . https://doi.org/10.3390/microorganisms9040758
Endoh, Rikiya, et al. "D-Fructose Assimilation and Fermentation by Yeasts Belonging to Saccharomycetes: Rediscovery of Universal Phenotypes and Elucidation of Fructophilic Behaviors in ." Microorganisms vol. 9,4 (2021). doi: https://doi.org/10.3390/microorganisms9040758
Endoh R, Horiyama M, Ohkuma M. D-Fructose Assimilation and Fermentation by Yeasts Belonging to Saccharomycetes: Rediscovery of Universal Phenotypes and Elucidation of Fructophilic Behaviors in . Microorganisms. 2021 Apr 05;9(4). doi: 10.3390/microorganisms9040758. PMID: 33916327; PMCID: PMC8065679.
Copy Download .nbib Format: NLM
Construction of 1,2,3-Benzodiazaborole by Electrophilic Borylation of Azobenzene and Nucleophilic Dialkylative Cyclization.

Organic letters

Shigeno M, Imamatsu M, Kai Y, Kiriyama M, Ishida S, Nozawa-Kumada K, Kondo Y.
PMID: 34613748
Org Lett. 2021 Oct 15;23(20):8023-8027. doi: 10.1021/acs.orglett.1c03033. Epub 2021 Oct 06.

1,2,3-Benzodiazaboroles can be conveniently prepared from azobenzenes by a two-step protocol involving electrophilic

Cite
Shigeno M, Imamatsu M, Kai Y, et al. Construction of 1,2,3-Benzodiazaborole by Electrophilic Borylation of Azobenzene and Nucleophilic Dialkylative Cyclization. Org Lett. 2021;23(20):8023-8027doi: 10.1021/acs.orglett.1c03033.
Shigeno, M., Imamatsu, M., Kai, Y., Kiriyama, M., Ishida, S., Nozawa-Kumada, K., & Kondo, Y. (2021). Construction of 1,2,3-Benzodiazaborole by Electrophilic Borylation of Azobenzene and Nucleophilic Dialkylative Cyclization. Organic letters, 23(20), 8023-8027. https://doi.org/10.1021/acs.orglett.1c03033
Shigeno, Masanori, et al. "Construction of 1,2,3-Benzodiazaborole by Electrophilic Borylation of Azobenzene and Nucleophilic Dialkylative Cyclization." Organic letters vol. 23,20 (2021): 8023-8027. doi: https://doi.org/10.1021/acs.orglett.1c03033
Shigeno M, Imamatsu M, Kai Y, Kiriyama M, Ishida S, Nozawa-Kumada K, Kondo Y. Construction of 1,2,3-Benzodiazaborole by Electrophilic Borylation of Azobenzene and Nucleophilic Dialkylative Cyclization. Org Lett. 2021 Oct 15;23(20):8023-8027. doi: 10.1021/acs.orglett.1c03033. Epub 2021 Oct 06. PMID: 34613748.
Copy Download .nbib Format: NLM
Direct platelet adhesion potentiates group 2 innate lymphoid cell functions.

Allergy

Orimo K, Tamari M, Takeda T, Kubo T, Rückert B, Motomura K, Sugiyama H, Yamada A, Saito K, Arae K, Kuriyama M, Hara M, Soyka MB, Ikutani M, Yamaguchi S, Morimoto N, Nakabayashi K, Hata K, Matsuda A, Akdis CA, Sudo K, Saito H, Nakae S, Tamaoki J, Tagaya E, Matsumoto K, Morita H.
PMID: 34402091
Allergy. 2021 Aug 17; doi: 10.1111/all.15057. Epub 2021 Aug 17.

BACKGROUND: Platelets are thought to be involved in the pathophysiology of asthma, presumably through direct adhesion to inflammatory cells, including group 2 innate lymphoid cells (ILC2s). Here, we tried to elucidate the effects of platelet adhesion to ILC2s in...

Cite
Orimo K, Tamari M, Takeda T, et al. Direct platelet adhesion potentiates group 2 innate lymphoid cell functions. Allergy. 2021;doi: 10.1111/all.15057.
Orimo, K., Tamari, M., Takeda, T., Kubo, T., Rückert, B., Motomura, K., Sugiyama, H., Yamada, A., Saito, K., Arae, K., Kuriyama, M., Hara, M., Soyka, M. B., Ikutani, M., Yamaguchi, S., Morimoto, N., Nakabayashi, K., Hata, K., Matsuda, A., Akdis, C. A., Sudo, K., Saito, H., Nakae, S., Tamaoki, J., Tagaya, E., Matsumoto, K., & Morita, H. (2021). Direct platelet adhesion potentiates group 2 innate lymphoid cell functions. Allergy, . https://doi.org/10.1111/all.15057
Orimo, Keisuke, et al. "Direct platelet adhesion potentiates group 2 innate lymphoid cell functions." Allergy vol. (2021). doi: https://doi.org/10.1111/all.15057
Orimo K, Tamari M, Takeda T, Kubo T, Rückert B, Motomura K, Sugiyama H, Yamada A, Saito K, Arae K, Kuriyama M, Hara M, Soyka MB, Ikutani M, Yamaguchi S, Morimoto N, Nakabayashi K, Hata K, Matsuda A, Akdis CA, Sudo K, Saito H, Nakae S, Tamaoki J, Tagaya E, Matsumoto K, Morita H. Direct platelet adhesion potentiates group 2 innate lymphoid cell functions. Allergy. 2021 Aug 17; doi: 10.1111/all.15057. Epub 2021 Aug 17. PMID: 34402091.
Copy Download .nbib Format: NLM
Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer.

Molecular and clinical oncology

Nagata T, Kanamori M, Sekine S, Arai M, Moriyama M, Fujii T.
PMID: 33796292
Mol Clin Oncol. 2021 May;14(5):103. doi: 10.3892/mco.2021.2265. Epub 2021 Mar 17.

Modulated electro-hyperthermia (mEHT) is a new treatment modality developed to overcome the problems associated with traditional hyperthermia; mEHT uses a precise impedance-matched system and modulated radiofrequency current flow to malignant tumors. It selects the malignant cells based on their...

Cite
Nagata T, Kanamori M, Sekine S, et al. Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer. Mol Clin Oncol. 2021;14(5):103doi: 10.3892/mco.2021.2265.
Nagata, T., Kanamori, M., Sekine, S., Arai, M., Moriyama, M., & Fujii, T. (2021). Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer. Molecular and clinical oncology, 14(5), 103. https://doi.org/10.3892/mco.2021.2265
Nagata, Takuya, et al. "Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer." Molecular and clinical oncology vol. 14,5 (2021): 103. doi: https://doi.org/10.3892/mco.2021.2265
Nagata T, Kanamori M, Sekine S, Arai M, Moriyama M, Fujii T. Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer. Mol Clin Oncol. 2021 May;14(5):103. doi: 10.3892/mco.2021.2265. Epub 2021 Mar 17. PMID: 33796292; PMCID: PMC8010507.
Copy Download .nbib Format: NLM
Showing 1225 to 1235 of 1235 entries